Study of Immunotherapy (Sasanlimab) in Combination With Targeted Therapies in People With Advanced Non-small Cell Lung Cancer (NSCLC) (Landscape 1011 Study)
Clinical trial NCT04585815 · TERMINATED
Trial details
- NCT number
- NCT04585815
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-10
- Primary completion
- 2023-05-17
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.